NASDAQ: KYMR · Health Care / Biotechnology: Biological Products (No Diagnostic Substances)

Kymera Therapeutics Inc.

How Kymera Therapeutics Inc. compares with its industry, its sector and the market: price, value, growth, profit and risk.

Market cap

$10.2B

Price

$122.60

P/E

-29.9

EPS (TTM)

$-4.10

1-year return

104.2%

Dividend yield

0.0%

52-week range

$64.63–$122.60

Compared with

• Biotechnology: Biological Products (No Diagnostic Substances) industry
• Health Care sector

For information only, not investment advice. Data may contain errors. Disclaimer · Sources